Connect your AI

MAZE MAZE Interest income and other, net

Interest income and other, net at other companies

Nurix Therapeutics, Inc.NRIX

——

Other financials

Income statement

Revenue$20.0M—

Operating income-$26.6M+25.0%

Net income-$24.2M+26.2%

EPS (diluted)-$0.45+60.9%

Balance sheet

Cash & equivalents$198.8M-32.5%

Total debt$61.2M+137%

Total equity$341.7M+17.0%

Total assets$419.7M+26.1%

Cash flow

Operating cash flow-$39.1M-32.5%

CapEx$93.0K-68.9%

Free cash flow-$39.2M-31.5%

Valuation

Market cap$1.48B+201%

Enterprise value$1.34B—

P/S7.9×—

Profitability

Operating margin-71.5%—

Net margin-65.4%—

FCF margin-65.1%—

Returns & leverage

Return on equity-38.7%—

Debt / equity0.2×+0.1×

Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's interest income and other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is MAZE's interest income and other, net?: MAZE (MAZE) reported interest income and other, net of $3.21M in Q1 2026.
How has MAZE's interest income and other, net changed year-over-year?: MAZE's interest income and other, net increased by 22.8% year-over-year, from $2.62M to $3.21M.